8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      PAX1 is essential for development and function of the human thymus

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We investigated the molecular and cellular basis of severe combined immunodeficiency (SCID) in six patients with otofaciocervical syndrome type 2 who failed to attain T cell reconstitution after allogeneic hematopoietic stem cell transplantation, despite successful engraftment in three of them. We identified rare bi-allelic PAX1 rare variants in all patients. We demonstrated that these mutant PAX1 proteins have an altered conformation and flexibility of the paired box domain and reduced transcriptional activity. We generated patient-derived induced pluripotent stem cells and differentiated them into thymic epithelial progenitor cells, and found that they have an altered transcriptional profile, including for genes involved in the development of the thymus and other tissues derived from pharyngeal pouches. These results identify bi-allelic, loss-of-function PAX1 mutations as the cause of a syndromic form of SCID due to altered thymus development.

          One Sentence Summary

          PAX1 deficiency causes a syndromic form of SCID by altering differentiation of thymic epithelial cells and other pharyngeal pouch tissues.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          p63 Is essential for the proliferative potential of stem cells in stratified epithelia.

          The distinguishing feature of adult stem cells is their extraordinary capacity to divide prior to the onset of senescence. While stratified epithelia such as skin, prostate, and breast are highly regenerative and account disproportionately for human cancers, genes essential for the proliferative capacity of their stem cells remain unknown. Here we analyze p63, a gene whose deletion in mice results in the catastrophic loss of all stratified epithelia. We demonstrate that p63 is strongly expressed in epithelial cells with high clonogenic and proliferative capacity and that stem cells lacking p63 undergo a premature proliferative rundown. Additionally, we show that p63 is dispensable for both the commitment and differentiation of these stem cells during tissue morphogenesis. Together, these data identify p63 as a key, lineage-specific determinant of the proliferative capacity in stem cells of stratified epithelia.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.

            Severe influenza disease strikes otherwise healthy children and remains unexplained. We report compound heterozygous null mutations in IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy child who suffered life-threatening influenza during primary infection. In response to influenza virus, the patient's leukocytes and plasmacytoid dendritic cells produced very little type I and III interferons (IFNs). Moreover, the patient's dermal fibroblasts and induced pluripotent stem cell (iPSC)-derived pulmonary epithelial cells produced reduced amounts of type I IFN and displayed increased influenza virus replication. These findings suggest that IRF7-dependent amplification of type I and III IFNs is required for protection against primary infection by influenza virus in humans. They also show that severe influenza may result from single-gene inborn errors of immunity. Copyright © 2015, American Association for the Advancement of Science.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment

              Thymic T cell lineage commitment is dependent on Notch1 (N1) receptor–mediated signaling. Although the physiological ligands that interact with N1 expressed on thymic precursors are currently unknown, in vitro culture systems point to Delta-like 1 (DL1) and DL4 as prime candidates. Using DL1- and DL4-lacZ reporter knock-in mice and novel monoclonal antibodies to DL1 and DL4, we show that DL4 is expressed on thymic epithelial cells (TECs), whereas DL1 is not detected. The function of DL4 was further explored in vivo by generating mice in which DL4 could be specifically inactivated in TECs or in hematopoietic progenitors. Although loss of DL4 in hematopoietic progenitors did not perturb thymus development, inactivation of DL4 in TECs led to a complete block in T cell development coupled with the ectopic appearance of immature B cells in the thymus. These immature B cells were phenotypically indistinguishable from those developing in the thymus of conditional N1 mutant mice. Collectively, our results demonstrate that DL4 is the essential and nonredundant N1 ligand responsible for T cell lineage commitment. Moreover, they strongly suggest that N1-expressing thymic progenitors interact with DL4-expressing TECs to suppress B lineage potential and to induce the first steps of intrathymic T cell development.
                Bookmark

                Author and article information

                Journal
                101688624
                45516
                Sci Immunol
                Sci Immunol
                Science immunology
                2470-9468
                13 April 2020
                28 February 2020
                28 August 2020
                : 5
                : 44
                : eaax1036
                Affiliations
                [1 ]Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD 20892, USA
                [2 ]Human and Molecular Genetics Center, Medical College Wisconsin, Milwaukee, MI, USA
                [3 ]Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, MD 20892, USA
                [4 ]Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
                [5 ]Cytogenetic and Medical Genetics Unit, “A. Nocivelli” Institute for Molecular Medicine, Spedali Civili Hospital, Brescia, Italy
                [6 ]Coyote Bioscience USA Inc., San Jose, CA 95138, USA
                [7 ]Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, College of Medicine, Cincinnati, OH 45229, USA
                [8 ]Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia
                [9 ]Saudi Human Genome Program, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
                [10 ]Division of Pediatric Allergy and Immunology, Mayo Clinic Children’s Center, Rochester, MN, USA
                [11 ]Genomic Technologies Section, NIAID, NIH, Bethesda, MD 20892, USA
                [12 ]Research Technologies Branch, DIR, NIAID, NIH, Bethesda, MD 20892, USA
                [13 ]Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
                [14 ]Department of Radiology, Mayo Clinic, Rochester, MN, USA
                [15 ]Alfaisal University, Riyadh, Saudi Arabia
                [16 ]GeneDx Inc., Gaithersburg, MD 20877, USA
                [17 ]PerkinElmer Genomics, Pittsburgh, PA 15275, USA
                [18 ]Cancer and Blood Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, College of Medicine, Cincinnati, OH 45229, USA
                [19 ]St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA
                [20 ]Laboratory of Human Genetics of Infectious Diseases, Necker Branch INSERM, Necker Hospital for Sick Children, Paris, France
                [21 ]Paris Descartes University, Imagine Institute, Paris, France
                [22 ]Pediatric Immunology, Department of Health Sciences, University of Florence, Florence, Italy
                [23 ]Meyer Children’s Hospital, Florence, Italy
                [24 ]Department of Pediatrics, Allergy and Immunology Section, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia
                [25 ]Pediatrics Hematology-Immunology Unit, Necker Hospital for Sick Children, Paris, France
                [26 ]Howard Hughes Medical Institute, New York, NY 10065, USA
                [27 ]Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
                [28 ]Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital, Columbus, OH 43205, USA
                [29 ]Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, China
                [30 ]Aperiomics, Inc., Sterling, VA 20166, USA
                Author notes

                Author contributions: YY performed experiments and wrote the manuscript; RU performed structural modeling and molecular dynamics simulation studies; LF supervised analysis of RNAseq and GSEA data; FO-C and TM assisted with RNAseq studies; SG and SM performed Sanger sequencing and Western blot analysis, and analyzed WES data; KZ, AMA, HA, FZ, CAV and BB performed and analyzed WES; AKD generated iPSCs; AJ, RWM, AHF, CA, BKA-S, and H-AM provided clinical care and description of the patients; FF performed lymph node pathology; MPB, MLH and CM performed and interpreted imaging studies; JLC and RSA contributed to supervision of the project and to writing of the manuscript; LDN was responsible for the entire research project and wrote the manuscript.

                [* ]Corresponding author. luigi.notarangelo2@ 123456nih.gov
                Article
                PMC7189207 PMC7189207 7189207 nihpa1582685
                10.1126/sciimmunol.aax1036
                7189207
                32111619
                b372b1e6-e9c9-44d8-8a04-ad8eac03d403
                History
                Categories
                Article

                Comments

                Comment on this article